Needham & Company increased its target price and gave a 'buy' rating for Plexus on July 31, 2026.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company increased its target price and gave a 'buy' rating for Plexus on July 31, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Needham & Company
American independent investment bank and asset management firm
Related events
- Needham & Company increased its target price and gave a buy rating for ICU Medical.
- Needham & Company raised its price target and issued a buy rating for Unusual Machines, Inc., while insider transactions were also disclosed via SEC filings.
- Needham & Company and Citigroup issued rating updates, concurrent with an insider sale disclosure filed with the SEC.